We are thrilled to announce that the Lymphedema Advocacy Group is a finalist for a RareVoice award! 

This award celebrates and honors advocates and organizations who help amplify the voice of the rare disease community in state and federal policy on Capitol Hill. The EveryLife Foundation’s website lists all the finalists

If you are in the DC area or plan to be next week, you are invited to join us at the awards ceremony on Wednesday evening, December 13th. The event is free to attend and includes a reception, but you must register in advance

Additional information can be found at the above link. We’d love to see you there!

Heather Ferguson
Founder & Executive Director
Lymphedema Advocacy Group
LymphedemaTreatmentAct.org

 


Below is a summary of the LTA final rule. You can read the full 65 pages here. We have also inserted notes into our group’s public comment document, which can be read here, to indicate which of our comments were incorporated into the final rule.

The final rule is a huge victory for patients, but our work is not done yet. Please visit our Take Action page if you have any insurance plan other than traditional Medicare and haven’t contacted your own insurance provider yet. 

Lymphedema Treatment Act Final Rule Coverage Summary

What will be covered:

Frequency allowances:

Coverage requirements:

Codes and reimbursement rates:

Deductibles and copay:

 

PLEASE NOTE: The final rule also outlines the process for making future changes to and/or additions to coverage if/when needed. This is very important, and ensures we will not be in the position of needing to get another law passed if adjustments to the coverage need to be made, or if new treatment supplies become available and need to be added to coverage.

Together, our advocacy made all of this possible!